Mitochondrial sirtuins: Regulators of protein acylation and metabolism

Trends in Endocrinology and Metabolism

Volumn 23, Issue 9, 2012, Pages 467-476

  He, Wenjuan ^a   Newman, John C ^a   Wang, Margaret Z ^a   Ho, Linh ^a   Verdin, Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Lysine acylation; Metabolism; Mitochondria; Sirtuins

Indexed keywords

BUTYRYL COENZYME A DEHYDROGENASE; MALONYL COENZYME A; MITOCHONDRIAL ENZYME; MITOCHONDRIAL PROTEIN; PROPIONYL COENZYME A; REACTIVE OXYGEN METABOLITE; SIRTUIN; SIRTUIN 3; SIRTUIN 3 DEACETYLASE; SIRTUIN 4; SIRTUIN 5; SUCCINYL COENZYME A; UNCLASSIFIED DRUG;

ACYLATION; AGING; CARBOHYDRATE METABOLISM; DEACETYLATION; ENERGY METABOLISM; ENZYME ACTIVITY; LIPID METABOLISM; METABOLIC DISORDER; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; NITROGEN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW;

ACYLATION; ANIMALS; HUMANS; MITOCHONDRIAL PROTEINS; SIRTUINS;

EID: 84865421953     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2012.07.004     Document Type: Review

References (97)

1. Alberts B. Molecular Biology of the Cell 2008, Garland Science.
2. Schiff M., et al. Mitochondrial response to controlled nutrition in health and disease. Nutr. Rev. 2011, 69:65-75.
3. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 2005, 39:359-407.
4. Wang C.H., et al. Mitochondrial dysfunction in insulin insensitivity: implication of mitochondrial role in type 2 diabetes. Ann. N. Y. Acad. Sci. 2010, 1201:157-165.
5. Haigis M.C., Sinclair D.A. Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 2010, 5:253-295.
6. Schwer B., Verdin E. Conserved metabolic regulatory functions of sirtuins. Cell Metab. 2008, 7:104-112.
7. Blander G., Guarente L. The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 2004, 73:417-435.
8. Houtkooper R.H., et al. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 2012, 13:225-238.
9. Ahn B.H., et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:14447-14452.
10. Lombard D.B., et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell. Biol. 2007, 27:8807-8814.
11. Verdin E., et al. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem. Sci. 2010, 35:669-675.
12. Haigis M.C., et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 2006, 126:941-954.
13. Du J., et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 2011, 334:806-809.
14. Peng C., et al. The first identification of lysine malonylation substrates and its regulatory enzyme. Mol. Cell. Proteomics 2011, 10. M111.012658 1-12.
15. Finkel T., et al. Recent progress in the biology and physiology of sirtuins. Nature 2009, 460:587-591.
16. Jing E., et al. Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:14608-14613.
17. Hirschey M.D., et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010, 464:121-125.
18. Shimazu T., et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab. 2010, 12:654-661.
19. Hirschey M.D., et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol. Cell 2011, 44:177-190.
20. Frye R.A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 2000, 273:793-798.
21. Choudhary C., et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009, 325:834-840.
22. Kim S.C., et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 2006, 23:607-618.
23. Weinert B.T., et al. Proteome-wide mapping of the Drosophila acetylome demonstrates a high degree of conservation of lysine acetylation. Sci. Signal. 2011, 4:ra48.
24. Wang Q., et al. Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science 2010, 327:1004-1007.
25. Zhao S., et al. Regulation of cellular metabolism by protein lysine acetylation. Science 2010, 327:1000-1004.
26. Hirschey M.D., et al. SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:267-277.
27. Schwer B., et al. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10224-10229.
28. Someya S., et al. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 2010, 143:802-812.
29. Shulga N., Pastorino J.G. Ethanol sensitizes mitochondria to the permeability transition by inhibiting deacetylation of cyclophilin-D mediated by sirtuin-3. J. Cell Sci. 2010, 123:4117-4127.
30. Shulga N., et al. Sirtuin-3 deacetylation of cyclophilin D induces dissociation of hexokinase II from the mitochondria. J. Cell Sci. 2010, 123:894-902.
31. Qiu X., et al. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 2010, 12:662-667.
32. Tao R., et al. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol. Cell 2010, 40:893-904.
33. Chen Y., et al. Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep. 2011, 12:534-541.
34. Kendrick A.A., et al. Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem. J. 2011, 433:505-514.
35. Schwer B., et al. Calorie restriction alters mitochondrial protein acetylation. Aging Cell 2009, 8:604-606.
36. Palacios O.M., et al. Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle. Aging 2009, 1:771-783.
37. Caton P.W., et al. PPARalpha-LXR as a novel metabolostatic signalling axis in skeletal muscle that acts to optimize substrate selection in response to nutrient status. Biochem. J. 2011, 437:521-530.
38. Hallows W.C., et al. Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol. Cell 2011, 41:139-149.
39. Tauriainen E., et al. Distinct effects of calorie restriction and resveratrol on diet-induced obesity and Fatty liver formation. J. Nutr. Metab. 2011, 2011:525094.
40. Alhazzazi T.Y., et al. Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer 2011, 117:1670-1678.
41. Gurd B.J., et al. In mammalian muscle, SIRT3 is present in mitochondria and not in the nucleus; and SIRT3 is upregulated by chronic muscle contraction in an adenosine monophosphate-activated protein kinase-independent manner. Metabolism 2012, 61:733-741.
42. Hokari F., et al. Muscle contractile activity regulates Sirt3 protein expression in rat skeletal muscles. J. Appl. Physiol. 2010, 109:332-340.
43. Koltai E., et al. Combined exercise and insulin-like growth factor-1 supplementation induces neurogenesis in old rats, but do not attenuate age-associated DNA damage. Rejuvenation Res. 2011, 14:585-596.
44. Lanza I.R., et al. Endurance exercise as a countermeasure for aging. Diabetes 2008, 57:2933-2942.
45. Bao J., et al. SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicity. Free Radic. Biol. Med. 2010, 49:1230-1237.
46. Kong X., et al. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS ONE 2010, 5:e11707.
47. Giralt A., et al. Peroxisome proliferator-activated receptor-gamma coactivator-1alpha controls transcription of the Sirt3 gene, an essential component of the thermogenic brown adipocyte phenotype. J. Biol. Chem. 2011, 286:16958-16966.
48. Pillai V.B., et al. Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J. Biol. Chem. 2010, 285:3133-3144.
49. Benigni A., et al. Disruption of the Ang II type 1 receptor promotes longevity in mice. J. Clin. Invest. 2009, 119:524-530.
50. Bellizzi D., et al. Identification of GATA2 and AP-1 Activator elements within the enhancer VNTR occurring in intron 5 of the human SIRT3 gene. Mol. Cells 2009, 28:87-92.
51. Flick F., Luscher B. Regulation of sirtuin function by posttranslational modifications. Front. Pharmacol. 2012, 3:29.
52. Olsen J.V., et al. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci. Signal. 2010, 3:ra3.
53. Fritz K.S., et al. 4-Hydroxynonenal inhibits SIRT3 via thiol-specific modification. Chem. Res. Toxicol. 2011, 24:651-662.
54. Wagner G.R., et al. Friedreich's ataxia reveals a mechanism for coordinate regulation of oxidative metabolism via feedback inhibition of the SIRT3 deacetylase. Hum. Mol. Genet. 2012, 21:2688-2697.
55. Hallows W.C., et al. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10230-10235.
56. Shimazu T., et al. Acetate metabolism and aging: An emerging connection. Mech. Ageing Dev. 2010, 131:511-516.
57. Berg J.M., et al. Biochemistry 2012, W.H. Freeman.
58. Schlicker C., et al. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J. Mol. Biol. 2008, 382:790-801.
59. Alhazzazi T.Y., et al. SIRT3 and cancer: tumor promoter or suppressor?. Biochim. Biophys. Acta 2011, 1816:80-88.
60. Bayley J.P., Devilee P. The Warburg effect in 2012. Curr. Opin. Oncol. 2012, 24:62-67.
61. Kim H.S., et al. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010, 17:41-52.
62. Finley L.W., et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell 2011, 19:416-428.
63. Kaelin W.G., Ratcliffe P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 2008, 30:393-402.
64. Pedersen P.L., et al. Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim. Biophys. Acta 2002, 1555:14-20.
65. Finley L.W., et al. Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity. PLoS ONE 2011, 6:e23295.
66. Cimen H., et al. Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry 2010, 49:304-311.
67. Stumvoll M., et al. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005, 365:1333-1346.
68. Fernandez-Marcos P.J., et al. Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis. Sci. Rep. 2012, 2:425.
69. Ahuja N., et al. Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J. Biol. Chem. 2007, 282:33583-33592.
70. Nasrin N., et al. SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J. Biol. Chem. 2010, 285:31995-32002.
71. Zhang Z., et al. Identification of lysine succinylation as a new post-translational modification. Nat. Chem. Biol. 2011, 7:58-63.
72. Nakagawa T., et al. SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 2009, 137:560-570.
73. Garland P.B., et al. Steady-state concentrations of coenzyme A, acetyl-coenzyme A and long-chain fatty acyl-coenzyme A in rat-liver mitochondria oxidizing palmitate. Biochem. J. 1965, 97:587-594.
74. Paik W.K., et al. Nonenzymatic acetylation of histones with acetyl-CoA. Biochim. Biophys. Acta 1970, 213:513-522.
75. Fritz K.S., et al. Mitochondrial acetylome analysis in a mouse model of alcohol-induced liver injury utilizing SIRT3 knockout mice. J. Proteome Res. 2012, 11:1633-1643.
76. Picklo M.J. Ethanol intoxication increases hepatic N-lysyl protein acetylation. Biochem. Biophys. Res. Commun. 2008, 376:615-619.
77. Saggerson D. Malonyl-CoA, a key signaling molecule in mammalian cells. Annu. Rev. Nutr. 2008, 28:253-272.
78. Dyck J.R., et al. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation. Circ. Res. 2004, 94:e78-e84.
79. Dyck J.R., et al. Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury. Circulation 2006, 114:1721-1728.
80. Tong L. Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery. Cell. Mol. Life Sci. 2005, 62:1784-1803.
81. Abu-Elheiga L., et al. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:12011-12016.
82. Abu-Elheiga L., et al. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 2001, 291:2613-2616.
83. Abu-Elheiga L., et al. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:10207-10212.
84. Abu-Elheiga L., et al. The subcellular localization of acetyl-CoA carboxylase 2. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:1444-1449.
85. Roe C.R., et al. Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J. Clin. Invest. 2002, 110:259-269.
86. Shimomura Y., et al. Regulation of branched-chain amino acid catabolism: nutritional and hormonal regulation of activity and expression of the branched-chain alpha-keto acid dehydrogenase kinase. Curr. Opin. Clin. Nutr. Metab. Care 2001, 4:419-423.
87. Suryawan A., et al. A molecular model of human branched-chain amino acid metabolism. Am. J. Clin. Nutr. 1998, 68:72-81.
88. Blomstrand E., et al. Branched-chain amino acids activate key enzymes in protein synthesis after physical exercise. J. Nutr. 2006, 136:269S-273S.
89. Brosnan J.T., Brosnan M.E. Branched-chain amino acids: enzyme and substrate regulation. J. Nutr. 2006, 136:207S-211S.
90. Chen Y., et al. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol. Cell. Proteomics 2007, 6:812-819.
91. Frye R.A. Evolution of sirtuins from archaea to vertebrates. Histone Deacetylases Transcriptional Regulation and Other Cellular Functions 2006, Humana Press, Ch. 8, 183-202. E. Verdin (Ed.).
92. Schuetz A., et al. Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin. Structure 2007, 15:377-389.
93. Xue L., et al. Acetylation-dependent regulation of mitochondrial ALDH2 activation by SIRT3 mediates acute ethanol-induced eNOS activation. FEBS Lett. 2012, 586:137-142.
94. +-dependent deacetylase SIRT3 regulates mitochondrial protein synthesis by deacetylation of the ribosomal protein MRPL10. J. Biol. Chem. 2010, 285:7417-7429.
95. Sundaresan N.R., et al. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J. Clin. Invest. 2009, 119:2758-2771.
96. Vempati R.K., et al. p300-mediated acetylation of histone H3 lysine 56 functions in DNA damage response in mammals. J. Biol. Chem. 2010, 285:28553-28564.
97. Sundaresan N.R., et al. SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol. Cell. Biol. 2008, 28:6384-6401.